Description
Dosage
Composition
Literature
FAQ
Reviews
Veterinary preparation for dogs, supporting the proper functioning of the heart and circulatory system. The active ingredients of the preparation have a positive effect on improving the physiological parameters of the heart. The product is recommended as a dietary supplement for dogs with cardiological ailments and heart muscle failure.
The advanced formula of the preparation is based on the highest quality active ingredients, the effects of which have been scientifically confirmed:
L-carnitine – has a positive effect on the heart and the circulatory system. It has a cardioprotective effect, improves the systolic and diastolic function of the heart. Reduces the risk of circulatory system diseases. An amino acid used in the treatment of ischemic heart disease, arrhythmias and cardiomyopathy. It has an antioxidant effect [1,2].
Taurine – improves myocardial contractility by regulating intracellular calcium ion concentration [3]. Taurine supplementation prevents hardening and narrowing of arteries in animals. Taurine deficiency may contribute to the development of cardiomyopathy [4,5,6,7].
Arginine – Causes blood vessels to dilate and relax, thus improving blood transport. Lowers blood lipid levels. Regulates blood pressure [8].
Coenzyme Q10 – improves exercise capacity in patients with heart failure [9,10]. Reduces the occurrence of atrial fibrillation (arrhythmia) and the risk of cardiac incidents [11,12]. It has strong antioxidant properties [13].
Folic acid (vit. B9) – has a beneficial effect on the heart by maintaining a proper level of homocysteine. Reduces the risk of stroke.
Alpha lipoic acid – prevents the development of heart diseases, reduces hypertension. It is an antioxidant, has a positive effect on the endothelium of blood vessels, and also protects the body from damage resulting from ischemia [14].
Potassium – protects against the development of cardiovascular diseases. Prevents the occurrence of arrhythmia. Regulates hypertension.
Magnesium – prevents uneven and accelerated heart function. It has an antispasmodic effect on blood vessels, thus preventing ischemia and the development of hypertension and ischemic heart disease.
Feeding: 1 tablet per day for every 15 kg of dog’s body weight. Dogs weighing less than 15 kg – 1 tablet per day. Dogs weighing more than 45 kg – 3 tablets per day.
In the case of diagnosed cardiac diseases, the target dose and duration of supplementation should be consulted with a veterinarian.
Available packages: 60 tablets.
Support for the heart and circulatory system
Cardiological diseases
Dosage
Cardio Protect
| 15 kg | 1 tablet | |
| 30 kg | 2 tablets | |
| 45 kg | 3 tablets |
Active substances
in 1 tablet
L-carnitine
500 mg
Taurine
200 mg
L-arginine
100 mg
Coenzyme Q10
20 mg
Folic acid
15 mg
Alpha Lipoic Acid
10 mg
Potassium
10 mg
Magnesium
20 mg
Composition
magnesium citrate, potassium chloride, alpha lipoic acid
Nutritional additives (g/kg)
L-carnitine tartrate 431 g, taurine 115 g, L-arginine 57 g, folic acid 9 g, coenzyme Q10 120 g
Technological additives (g/kg)
microcrytsalline cellulose 287g, magnesium stearate 3g
Analytical constituents
- crude oils and fats 5%
- protein 35%
- crude fibre 14%
- crude ash 2%
- Kittleson M.D., Keene B., Pion P.D. i wsp.: Results of the multicenter spaniel trial (MUST): taurine-and carnitine-responsive dilated cardiomyopathy in American cocker spaniels with decreased plasma taurine concentration. Journal of Veterinary Internal Medicine, 1997, 11, 204-211.
- Mirowski A.: Karnityna w dietetyce weterynaryjnej. Magwet, 05/2017.
- BackusC., Cohen G., Pion P.D. i wsp.: Taurine deficiency in Newfoundlands fed commercially available complete and balanced diets. J Am Vet Med Assoc., 2003, Oct 15, 223 (8), 1130-6.
- Kaplan J.L., Stern J.A., Fascetti J. i wsp.: Taurine deficiency and dilated cardiomyopathy in golden retrievers fed commercial diets. PLoS One, 2018, Dec 13, 13 (12), e0209112.
- OntiverosS., Whelchel B.D., Yu J. i wsp.: Development of plasma and whole blood taurine reference ranges and identification of dietary features associated with taurine deficiency and dilated cardiomyopathy in golden retrievers: a prospective, observational study. PLoS One, 2020, 15,
- BackusC., Cohen G., Pion P.D. i wsp.: Taurine deficiency in Newfoundlands fed commercially available complete and balanced diets. J Am Vet Med Assoc., 2003, Oct 15, 223 (8), 1130-6.
- Basili M., Pedro B., Hodgkiss-Geere i wsp.: Low plasma taurine levels in English cocker spaniels diagnosed with dilated cardiomyopathy. J Small Anim Pract., 2021, Jul, 62 (7), 570-579.
- King J.H., ChungS.: L-arginine in the treatment of cardiovascular disease in companion animals. Journal of Veterinary Cardiology, 1997, 25 (6), 419-422.
- De BlasioJ., Huynh K., Qin C. i wsp.: Therapeutic targeting of oxidative stress with coenzyme Q10 counteracts exaggerated diabetic cardiomyopathy in a mouse model of diabetes with diminished PI3K(p110alpha) signaling. Free Radic Biol Med, 2015, 87, 137-47.
- Druzhaeva Natalia, Alenka Nemec Svete, Gabrijela Tavčar-Kalcher, Janja Babič, Alojz Ihan, Katka Pohar, Uroš Krapež, Aleksandra Domanjko Petrič.: Effects of Coenzyme Q10 Supplementation on Oxidative Stress Markers, Inflammatory Markers, Lymphocyte Subpopulations, and Clinical Status in Dogs with Myxomatous Mitral Valve Disease. Antioxidants, 2022, 11, no. 8, 1427.
- ChristiansenB., Morsing M.K., Reimann M.J., Martinussen T., Birlie Z., Schou-Pedersen A.M.V., … Olsen L.H.: Pharmacokinetics of Repeated Oral Dosing with Coenzyme Q10 in Cavalier King Charles Spaniels with Myxomatous Mitral Valve Disease. Antioxidants, 2020, 9 (9), 827
- Al Saadi T., Assaf Y., Farwati M., Turkmani K., Al-Mouakeh A., Shebli, B., … Madmani M.E.: Coenzyme Q10 for heart failure. Cochrane Database of Systematic Reviews, 2021 (2).
- Christiansen L.B., Morsing M.K., Reimann M.J., Martinussen T., Birlie Z., Schou-Pedersen A.M.V., … Olsen L.H.: Pharmacokinetics of Repeated Oral Dosing with Coenzyme Q10 in Cavalier King Charles Spaniels with Myxomatous Mitral Valve Disease. Antioxidants, 2020, 9 (9), 827.
- Wollin SD, Jones PJ. Alpha-lipoic acid and cardiovascular disease. J Nutr. 2003 Nov;133(11):3327-30.
Does this product replace medication?
No, this product will not replace medication, but it works great in dietary therapy for heart disease.
Can this product be used preventively?
Yes, it is worth using this product as a preventive measure in dogs predisposed to heart disease.
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.